Effects of NADPH oxidase inhibitor in diabetic nephropathy

Kidney International

Volumn 67, Issue 5, 2005, Pages 1890-1898

  Asaba, Kensuke ^b   Tojo, Akihiro ^a   Onozato, Maristela Lika ^b   Goto, Atsuo ^b   Quinn, Mark T ^b   Fujita, Toshiro ^b   Wilcox, Christopher S ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

Apocynin; Diabetic nephropathy; NADPH oxidase; Nitric oxide synthase; Proteinuria

Indexed keywords

APOCYNIN; COLLAGEN TYPE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; HYDROGEN PEROXIDE; NITRIC OXIDE; PROTEIN; PROTEIN P47PHOX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; LIPID PEROXIDATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; STREPTOZOCIN DIABETES;

EID: 17744364508     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00287.x     Document Type: Article

References (52)

1. HA H, LEE HB: Oxidative stress in diabetic nephropathy: Basic and clinical information. Curr Diab Rep 1:282-287, 2001
2. ONOZATO ML, TOJO A, GOTO A, et al: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. kidney Int 61:186-194, 2002
3. BABIOR BM: NADPH oxidase. Curr Opin Immunol 16:42-47, 2004
4. LI WG, MILLER FJ, JR., ZHANG HJ, et al: H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276:29251-29256, 2001
5. GRIENDLING KK, SORESCU D, USHIO-FUKAI M: NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86:494-501, 2000
6. CHABRASHVILI T, TOJO A, ONOZATO ML, et al: Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269-274, 2002
7. HART BA, SIMONS JM: Metabolic activation of phenols by stimulated neutrophils: A concept for a selective type of anti-inflammatory drug. Biotechnol Ther 3:119-135, 1992
8. MEYER JW, SCHMITT ME: A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett 472:1-4, 2000
9. HART BA, SIMONS JM, KNAAN-SHANZER S, et al: Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radic Biol Med 9:127-131, 1990
10. RACHMILEWITZ D, OKON E, KARMELI F: Sulphydryl blocker induced small intestinal inflammation in rats: A new model mimicking Crohn's disease. Gut 41:358-365, 1997
11. BESWICK RA, DORRANCE AM, LEITE R, et al: NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38:1107-1111, 2001
12. COTTER MA, CAMERON NE: Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci 73:1813-1824, 2003
13. KAWAI J, ANDO K, TOJO A, et al: Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation 109:1147-1153, 2004
14. PARK YM, PARK MY, SUH YL, et al: NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun 313:812-817, 2004
15. SUPINSKI G, STOFAN D, NETHERY D, et al: Apocynin improves diaphragmatic function after endotoxin administration. J Appl Physiol 87:776-782, 1999
16. HA H, ENDOU H: Lipid peroxidation in isolated rat nephron segments. Am J Physiol 263:F201-207, 1992
17. ROSENKRANZ AR, SCHMALDIENST S, STUHLMEIER KM, et al: A microplate assay for the detection of oxidative products using 2′,7′- dichlorofluorescin-diacetate. J Immunol Methods 156:39-45, 1992
18. ZHANG Z, RHINEHART K, SOLIS G, et al: Chronic Ang II infusion increases NO generation by rat descending vasa recta. Am J Physiol Heart Circ Physiol 288:H29-36, 2005
19. BREMER V, TOJO A, KIMURA K, et al: Role of nitric oxide in rat nephrotoxic nephritis: Comparison between inducible and constitutive nitric oxide synthase. J Am Soc Nephrol 8:1712-1721, 1997
20. TOJO A, KIMOTO M, WILCOX CS: Renal expression of constitutive NOS and DDAH: Separate effects of salt intake and angiotensin. Kidney Int 58:2075-2083, 2000
21. AKIMOVA OA, DOLGOVA NV, MAST NV, et al: Revealing of proteins interacting with Na,K-ATPase. Biochemistry (Mosc) 68:1040-1047, 2003
22. TOJO A, GROSS SS, ZHANG L, et al: Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney. J Am Soc Nephrol 4:1438-1447, 1994
23. RHINEHART KL, PALLONE TL: Nitric oxide generation by isolated descending vasa recta. Am J Physiol Heart Circ Physiol 281:H316-324, 2001
24. SAITO T, SUMITHRAN E, GLASGOW EF, et al: The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int 32:691-699, 1987
25. TOJO A, KIMURA K, NANBA S, et al: Variations in renal arteriolar diameter in deoxycorticosterone acetate-salt hypertensive rats. A microvascular cast study. Virchows Arch A Pathol Anat Histopathol 417:389-393, 1990
26. WILCOX CS, WELCH WJ, MURAD F, et al: Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A 89:11993-11997, 1992
27. BACHMANN S, BOSSE HM, MUNDEL P: Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol 268:F885-898, 1995
28. BONIZZI G, PIETTE J, SCHOONBROODT S, et al: Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol 19:1950-1960, 1999
29. DE KEULENAER GW, ALEXANDER RW, USHIO-FUKAI M, et al: Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329:653-657, 1998
30. JAIMES EA, GALCERAN JM, RAIJ L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54:775-784, 1998
31. KITIYAKARA C, CHABRASHVILI T, CHEN Y, et al: Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14:2775-2782, 2003
32. STOLK J, HILTERMANN TJ, DIJKMAN JH, et al: Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 11:95-102, 1994
33. TOUYZ RM, CHEN X, TABET F, et al: Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90:1205-1213, 2002
34. GJERTSEN FB, SOLHEIM E, SCHELINE RR: Metabolism of aromatic plant ketones in rats: Acetovanillone and paeonol. Xenobiotica 18:225-234, 1988
35. BEN-SHAUL V, LOMNITSKI L, NYSKA A, et al: The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol Lett 123:1-10, 2001
36. DODD OJ, PEARSE DB: Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol 279:H303-312, 2000
37. MCNALLY JS, DAVIS ME, GIDDENS DP, et al: Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285:H2290-2297, 2003
38. KOMERS R, ANDERSON S: Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284:F1121-1137, 2003
39. KING AJ, TROY JL, ANDERSON S, et al: Nitric oxide: A potential mediator of amino acid-induced renal hyperemia and hyperfiltration. J Am Soc Nephrol 1:1271-1277, 1991
40. THOMSON SC, DENO A, KOMINE N, et al: Early diabetes as a model for testing the regulation of juxtaglomerular NOS I. Am J Physiol Renal Physiol 287:F732-738, 2004
41. BRANDS MW, BELL TD, GIBSON B: Nitric oxide may prevent hypertension early in diabetes by counteracting renal actions of superoxide. Hypertension 43:57-63, 2004
42. BRODSKY SV, GAO S, LI H, et al: Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol 283:H2130-2139, 2002
43. KAKOKI M, HIRATA Y, HAYAKAWA H, et al: Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol 11:301-309, 2000
44. KATUSIC ZS: Vascular endothelial dysfunction: Does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 281:H981-986, 2001
45. LANDMESSER U, DIKALOV S, PRICE SR, et al: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201-1209, 2003
46. LAFEBER FP, BEUKELMAN CJ, VAN DEN WORM E, et al: Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 38:1088-1093, 1999
47. MEYER TN, SCHWESINGER C, YE J, et al: Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. J Biol Chem 276:22048-22055, 2001
48. LEE HB, YU MR, SONG JS, et al: Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 65:1170-1179, 2004
49. SERCOMBE R, VICAUT E, OUDART N, et al: Acetylcholine-induced relaxation of rabbit basilar artery in vitro is rapidly reduced by reactive oxygen species in acute hyperglycemia: Role of NADPH oxidase. J Cardiovasc Pharmacol 44:507-516, 2004
50. PRIVRATSKY JR, WOLD LE, SOWERS JR, et al: AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: Role of the AT1 receptor and NADPH oxidase. Hypertension 42:206-212, 2003
51. YOO C, SONG C, KIM B, et al: Glycated albumin induces superoxide generation in mesangial cells. Cell Physiol Biochem 14:361-368, 2004
52. SONTA T, INOGUCHI T, TSUBOUCHI H, et al: Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 37:115-123, 2004